NorthWest Biotherapeutics Inc (NWBO)

[Barunuuk]

In my mind, the end results beat out Optune's result considerably. From my calculations, PFS results will be outstanding, somewhere > 15 months median value. OS results could be a bit different, I believe OS results will be much better overall (as they have stated), and median value will probably be > 21 months. What could hurt the trial, is that both placebo and vaccinated populations increase > 21 months, but there may not be a 2 month difference. HOWEVER, I think that with a HUGE PFS increase, and an OVERALL OS increase > 21 months, even if DCVax-L is only 1.9 months better (~22.9 months), there will be a very good chance that it will be approved.